Financial sources for biotechnology companies in Germany 2005 to 2022

Published by Statista Research Department, Apr 15, 2024

In 2022, biotechnology companies in Germany received around 475 million euros from risk capital. Since 2011 the amount of money invested in biotechnology companies has rapidly increased. 2020 and 2021 were by far the most successful years for funding.

Sources of financing for biotechnology companies in Germany 2005 to 2022 (in million euros)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

July 2023

Region

Germany

Survey time period

2005 to 2022

Supplementary notes

The statistic refers to companies whose main corporate objective is the use of biotechnical processes to produce products or provide services.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Biotechnology in Germany "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Biotechnology in Germany

Overview

8

Biopharmaceutical market

8

Research and components

6

Funding

4

Occupation

3

Further Content: You might find this interesting as well

Topics

Biotechnology industry in Germany Global pharmaceutical industryBiotech drugs
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu